Connection

Charles Bennett to Androgen Antagonists

Back to Details
This is a "connection" page, showing publications Charles Bennett has written about Androgen Antagonists.
Charles Bennett
Connection Strength
1.376
Androgen Antagonists
  1. Editorial comment. Urology. 2015 Feb; 85(2):413.
    View in: PubMed
    Score: 0.457
  2. Combined androgen blockade with nonsteroidal antiandrogens for advanced prostate cancer: a systematic review. Urology. 2001 Apr; 57(4):727-32.
    View in: PubMed
    Score: 0.175
  3. Association Between Androgen Deprivation Therapy and Patient-reported Depression in Men With Recurrent Prostate Cancer. Clin Genitourin Cancer. 2018 08; 16(4):313-317.
    View in: PubMed
    Score: 0.144
  4. Cost-effective models for flutamide for prostate carcinoma patients: are they helpful to policy makers? Cancer. 1996 May 01; 77(9):1854-61.
    View in: PubMed
    Score: 0.125
  5. High PSA anxiety and low health literacy skills: drivers of early use of salvage ADT among men with biochemically recurrent prostate cancer after radiotherapy? Ann Oncol. 2015 Jul; 26(7):1390-5.
    View in: PubMed
    Score: 0.116
  6. The utility of prostate-specific antigen in the management of advanced prostate cancer. BJU Int. 2013 Sep; 112(5):548-60.
    View in: PubMed
    Score: 0.102
  7. Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol. 2007 Apr 20; 25(12):1596-605.
    View in: PubMed
    Score: 0.066
  8. Systematic review and meta-analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma. Cancer. 2002 Jul 15; 95(2):361-76.
    View in: PubMed
    Score: 0.048
  9. Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis. Ann Intern Med. 2000 Apr 04; 132(7):566-77.
    View in: PubMed
    Score: 0.041
  10. Maximal androgen blockade for advanced prostate cancer. Cochrane Database Syst Rev. 2000; (2):CD001526.
    View in: PubMed
    Score: 0.040
  11. Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer. Evid Rep Technol Assess (Summ). 1999 May; (4):i-x, 1-246, I1-36, passim.
    View in: PubMed
    Score: 0.038
  12. Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer. BJU Int. 2012 Jul; 110(2):201-5.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.